Skip directly to content

Working with the NHS and other Healthcare Organisations


Hear from the people who created the vision for ‘EPIFFANY’’, a number of collaborations between University Hospitals of Leicester NHS Trust, Health Education East Midlands, University of Leicester and Pfizer. This video describes the initial pilot project which was supported by Pfizer via a Medical and Educational Goods and Services (MEGS). See below for description of MEGS

We believe together works better.

The NHS is changing and the needs of our partners and the people they care for reflect this. We believe that through working in partnership, combining our skills, experience and resources, we can work towards delivering better patient care; united with the common goal of putting patients at the heart of our health service.

Pfizer has a rich heritage of working in the UK. Over the past sixty years, we have discovered and developed medicines which have improved and saved the lives of millions of people across Britain and around the world. 

As well as being a leading supplier of medicines to the NHS, we are committed to working with our partners from across the NHS, as well as academia and other healthcare organisations (HCOs), to improve the delivery of healthcare and achieve the best health outcomes for people in the UK.

Our work with the NHS and other healthcare organisations is described below and made public within our annual disclosure reports.


Joint Working

Joint Working describes situations where the NHS and pharmaceutical organisations pool skills, experience and/or resources for the joint development and implementation of patient-centred projects with a shared commitment to successful delivery.

Our Joint Working collaborations around the UK will always focus on delivering better patient outcomes first, as well as addressing NHS priorities.

Read more about our current Joint Working projects


Medical and Educational Goods and Services and other types of donations and grants

Medical and Educational Goods and Services (MEGS) are either financial grants, or services delivered by a Pfizer colleague or supplier engaged by Pfizer. MEGS are intended to either enhance patient care or benefit the NHS and maintain patient care. Our involvement is strictly limited to the provision or delivery of the MEGS grant or service and we do not expect to receive any benefit in return. MEGS do not constitute an inducement to prescribe, supply, administer, recommend, buy or sell any medicine.

We are proud to support patients and the NHS through MEGS but we do not proactively share detailed outcomes analyses of these projects; instead, the decision to share more in-depth information is at the discretion of the healthcare organisations themselves.

Read more about Medical and Educational Goods and Services and other types of donations and grants.


Corporate Sponsorships

Through corporate sponsorships, Pfizer provides funding to a third party in support of a project such as meetings, events or publications.  Unlike MEGS, corporate sponsorships do allow the sponsoring company to receive some form of benefit such as an opportunity to talk about Pfizer’s products, brands or business interests. For example, we may provide a corporate sponsorship to a healthcare organisation to run a medical meeting and at that meeting, have information available to attendees on one of our projects, services or – where appropriate – medicines.

Details about our corporate sponsorships are captured and made public within our annual disclosure reports.

PP-PFE-GBR-0633 / Sept 2017